DOH Logo linking to Home Page
 

epiTRENDS

Blue Line Image
You are here: DOH Home » EHSPHL » Communicable Disease Epidemiology » epiTRENDS Search | Employees
 

Print format of this article (.pdf)        Download free Adobe Acrobat Reader        Subscribe to epiTRENDS

Methicillin Resistant Staphylococcus aureus (MRSA)
November
2007                                                                                                      Vol. 12, No. 11    

Within a few years after antibiotics were introduced, some bacteria began demonstrating resistance to those drugs.  Increasing variety and volume of antibiotic use has predictably resulted in emergence of a widening array of antibiotic resistant organisms.  Among these are Staphylococcus aureus (staph) with resistance to penicillin-type antibiotics (organisms known as methicillin resistant S. aureus or MRSA). 

A third of the population may have staph colonization of body areas such as nose, armpits, vagina or rectum, with less than one percent estimated to have MRSA colonization.  staph can be spread from person to person through skin contact or from sharing contaminated items such as towels or razors.

Most staph infections are mild, occurring as boils, abscesses, infection of the hair follicles, or other soft tissue infection often starting with a break in the skin.  Some infections are mistaken for a spider bite.  Many mild infections can be treated simply by draining the infection.  staph also causes serious infections of the bloodstream, lungs, or surgical wounds that require antibiotic treatment.  MRSA can be treated with other common antibiotics, although different MRSA strains may have different antibiotic sensitivities.

Risks for MRSA Infections

    epiTRENDS
    P.O. Box 47812
    Olympia, WA 98504-7812


 
Mary C. Selecky
    Secretary
  Maxine Hayes, MD, MPH
    State Health Officer
  Marcia J. Goldoft, MD, MPH
    Scientific Editor
  Deborah Todd, RN, MPH
    Managing Editor

Medical and exposure risks for MRSA infections include:

Most invasive MRSA infections are healthcare-associated which means they occur among people currently or recently in a healthcare facility including hospitals, dialysis centers, and nursing homes.  These cases typically have medical risk factors for MRSA.  Community-associated infections occur in previously healthy individuals without medical risk factors.

Healthcare- versus Community-Associated MRSA

In the past there was generally a difference between MRSA strains causing healthcare-associated MRSA and community-associated MRSA.  Healthcare-associated strains were varied, showed multiple patterns of antibiotic resistance, and affected patients with existing medical conditions.  Community-associated strains were more uniform and more likely to affect healthy persons.  Recently the distinction has lessened as MRSA strains became more common in both healthcare and community settings.

A recent article in JAMA (October 17, 2007) reported results of surveillance for MRSA in nine U.S. sites during 2004 and 2005.  Reports were classified as either healthcare-associated or community-associated.  The overall rate of invasive MRSA was 31.8/100,000 population.  The majority of reports (85 percent) were healthcare-associated, although over half of those infections had onset in the community.  Infection rates were higher among persons 65 years and older.  About a fifth of cases were fatal.

Control Measures for MRSA

Patients with any skin infection including MRSA and their close contacts should be educated to prevent transmission. Fluids from staph infections and materials contaminated with fluids are both highly infectious.  *Inform any healthcare providers of the infection.

Control measures for persons with any skin infection include:

General control measures for MRSA are similar to those for any skin infection.  It is important to wash hands, particularly after touching a wound.  MRSA colonize the nose, so also wash hands after touching the nose or nasal secretions.

Transmission of MRSA occurs primarily through person-to-person contact.  It is not necessary to close facilities such as schools or offices for environmental disinfection when a case of MRSA is diagnosed or suspected.  Regular use of EPA-approved detergent based disinfectants are effective at removing MRSA from environmental surfaces, while covering infections with dressings and clothes will reduce the likelihood that surfaces will become contaminated.

Guidance Documents for MRSA

It is important for health care providers to remember that not all skin or soft tissue infections are MRSA or even staph, and not all antibiotic resistant organisms are staph.  When antibiotics are needed to treat skin and soft tissue infections, health care providers should choose antibiotics likely to cover the range of possible infections. A variety of guidance documents are available for preventing and treating MRSA and related infections.

Department of Health provides:

        Living with MRSA:
        http://www3.doh.wa.gov/here/materials/PDFs/12_MRSApage_E07L.pdf

        Interim guidelines for community-acquired infection in outpatient setting:
        http://www.doh.wa.gov/topics/Antibiotics/Documents/MRSAinterimGuidelines.pdf

Tacoma-Pierce County Department of Health has extensive information for prevention and control of MRSA infections in various settings including toolkits for outpatient clinics/offices, childcare centers, middle and high schools, athletic departments of middle and high schools, and elementary schools:

        http://www.tpchd.org/page.php?id=12

The Centers for Disease Control and Prevention (CDC) website includes general information as well as recommendations for healthcare settings:

        Strategies for clinical management:
        http://www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf

        Community-associated MRSA:
        http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html

        Healthcare-associated MRSA:
        http://www.cdc.gov/ncidod/dhqp/ar_mrsa.html

        MRSA data and statistics:
        http://www.cdc.gov/ncidod/dhqp/ar_mrsa_surveillanceFS.html


Documents posted in .pdf version on the Department of Health Web site will be made available in an alternative format on request to users who are unable to download or view .pdf files on the Web. To request an alternative format, contact: Webmaster.


DOH Home | Access Washington | Privacy Notice | Disclaimer/Copyright Information

Access Washington Logo linking to Access Washington Home Page

Washington State Department of Health
Communicable Disease Epidemiology
1610 N.E. 150th Street
Shoreline, WA 98155
Phone (206) 418-5500
FAX (206) 418-5515
24-hour contact 1-877-539-4344

Last Update : 11/21/2007 05:07 PM
Send inquires about DOH and its programs to the Health Consumer Assistance Office
Comments or questions regarding this web site? Send mail to the Subsite Developer.